|
Bioengineering
students provide solutions to many fundamental problems in Medicine
and Biology. If you are interested in a typical problem that was
solved by a UCSD bioengineering student, in the following you can
find a few recent examples. An answer to each question is given
in the listed publications.
Mechanotransduction by Fluid Shear
Q.
What is the fluid stress distribution on the membrane of a leukocyte actively migrating on substrate?
A. Su et al. 1997, 1998
Q.
To what degree do integrins control mechanotransduction of leukocytes by fluid shear stress?
A. Marschel et al., 2002
Microvascular Biorheology
Q.
What is the mechanism by which a very small number of circulating
leukocytes (less than 1%) can impose a large reduction of blood
flow in the microcirculation even without adhering to the endothelium?
A.
Helmke et al. 1997, 1998
Activated cells in the microcirculation, like leukocytes, may cause
complications and don't have the ability to freely circulate.
Q.
What
could be a mechanism by which leukocytes become deactivated ("downregulated")
in the circulation even though the cells have to be upregulated
in order to migrate from the bone marrow (where they are produced)
across the endothelium into the circulation?
A.
Moazzam
et al., 1997
The lymphatics, a unidirectional transport system for fluids and
immune cells.
Q.
Do lymphatics operate with just one valve system (the classical
intralymphatic bileaflet valves) as assumed in the past, or do they
need two valve systems ?
A.
Trzewik etal., 2001; Schmid-Schönbein
and Zweifach, 1994
Physiological shock, a condition with high mortality.
Q.
In which
organ(s) is the origin of the powerful inflammatory cell activators
that are detected already during the early phases of shock? Note
the answer to this question is of extraordinary importance for understanding
not only shock but may be also the origin of many other cardiovascular
diseases.
A.
Kistler
et al, 2000, Waldo et al., 2003
Q.
Is there a way
you may ever be able to block the lethal progression of physiological
shock ? If that were the case, medicine would have the tools to
avoid unnecessary deaths.
A.
Mitsuoka et al., 2000, 2002
Arterial hypertension is a vascular disease.
Q.
What
is the mechanism by which capillaries are destroyed in the microcirculation
of hypertensives?
A.
Vogt
et al., 2001, Tran et al., 2007
Q.
Can you
design a technology to measure oxgyen free radical production ("toxic
oxygen production") in hypertensive patients?
A.
Lacy
et al., 1998; Lacy et al., 1998
Q.
What may be a mechanism by which hypertensives become immune-suppressed?
A.
Suzuki et al., 1999; Suematsu
et al., 1995, DeLano et al., 2008
Q.
Can you
design an approach to block (at least in part) the excessive oxygen
free radical production in hypertensive patients ? The answer to
this question is of importance to companies that are trying to develop
medications for better treatment of hypertensive patients.
A.
Suzuki
et al., 1998; Swei et al., 1999 , Kobayashi et al., 2006
|